For the nation’s largest health insurer, the evidence of abuse was stunning and unmistakable: UnitedHealth Group reaped billions from the federal Medicare program by diagnosing
Enhancing healthcare research, Sapio Sciences’ solutions unify lab data management, leveraging AI to improve efficiency and accelerate drug development cycles.
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s
For people with obesity, surgeries that shrink, reshape, or otherwise alter the anatomy of the stomach have long reigned supreme as the surest way to
GSK has made its largest-ever single manufacturing investment in the US. Image credit: Shutterstock/ Golden Shrimp. Following outlays for sites in the UK and Belgium
Lyell intends to focus all its resources on CAR T-cell clinical programmes, with LYL119 and PmmPACT’s IMPT-314 being the lead candidates. Image credit: Andrii Yalanskyi
Agomab’s lead candidate is being investigated as a treatment for patients with fibrostenosing Crohn’s disease (FSCD). Credit: Hananeko_Studio via Shutterstock. Agomab Therapeutics has secured $89m
Dyno will leverage its platform and sequence design technologies to design and discover novel AAV capsids. Credit: metamorworks/Shutterstock. Dyno Therapeutics has formed a new research
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal
In this Issue Lykos’ Path to FDA Approval Might Include a Third-Party Review of Phase 3 Data, VA Funding of Phase 3 ‘Definitely a Possibility’